Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03860363 · ClinicalTrials.gov registry record
Experiences With Automated Surgical Drainage in Cardiac Surgery
A clinical trial, sponsored by Centese.
- Completed
- Registry status
- 28
- Enrollment target
NCT03860363: Completed study, sponsored by Centese.
NCT03860363 is a clinical trial that has completed, run by Centese. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03860363 has completed, sponsored by Centese.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the Thoraguard Surgical Drainage System in a real-world clinical environment. It is believed that this system will offer functional and clinical benefits over the current standard of care system for the removal of surgical fluids following cardiac surgery. Observations, experiences, and outcomes in a single hospital setting will be collected for the Thoraguard Surgical Drainage System.
Primary Outcome
The Device User Experience Survey is an unvalidated, Sponsor-generated questionnaire aimed to increase the Sponsor's understanding of the usability of the Thoraguard Surgical Drainage System. The questionnaire asks approximately 15 questions (includes yes/no responses, rating scales, and fill-in-the-blank sections) and is to be completed by the treating clinicians at the completion of the study. A summary of all treating clinician responses will be generated at the completion of the study to sum
Interventions
- DEVICE Blood drainage post cardiac surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-02-22 |
| Est. Completion | 2020-05-30 |
What the finished NCT03860363 record still lists
NCT03860363 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood drainage post cardiac surgery is the first listed.
NCT03860363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03860363 about?
NCT03860363 is a clinical study titled "Experiences With Automated Surgical Drainage in Cardiac Surgery". The purpose of this study is to evaluate the Thoraguard Surgical Drainage System in a real-world clinical environment. It is believed that this system will offer functional and clinical benefits over the current standard of care system for the removal of surgical fluids following cardiac surgery. Ob...
What is the current status of trial NCT03860363?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2019-02-22. Estimated completion is 2020-05-30.
What interventions are being tested in trial NCT03860363?
The interventions under investigation include: Blood drainage post cardiac surgery (DEVICE).
Who is sponsoring clinical trial NCT03860363?
This trial is sponsored by Centese, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI